A publication that assessed in leukemia cells a lonidamine + DON combination, observed an increased anti-leukemia effect when both inhibitors are used together28, and similar effects were observed in lung cancer cells, with the combination of lonidamine and the glutaminase inhibitor 96829. Here, GLS is linked to leukemia.